AbCellera Biologics Inc (HAM:8QQ)
€ 6.18 -0.68 (-9.91%) Market Cap: 1.90 Bil Enterprise Value: 1.58 Bil PE Ratio: 0 PB Ratio: 2.24 GF Score: 59/100

Abcellera Biologics Inc at JPMorgan Healthcare Conference Transcript

Jan 14, 2026 / 11:45 PM GMT
Release Date Price: €3.71 (+0.46%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ABCL.OQ - Abcellera Biologics Inc
Abcellera Biologics Inc at JPMorgan Healthcare Conference
Jan 14, 2026 / 11:45PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon ladies and gentlemen.

Welcome to the 2026 JPMorgan Healthcare Conference. My name is Varun, and it is my absolute pleasure to introduce on stage Appellera Biologics, joined by the CEO Carl Henson, who will talk about the company and their growth for the year. So please give a huge round of applause for Carl Henson.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
All right, thank you very much and thank you to the organizers of JP Morgan for the opportunity to speak. So today, my prepared remarks, I will TRY to keep pretty brief. For those
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot